WO1991015466A3 - Aminopolycarboxylic acid chelating agents - Google Patents

Aminopolycarboxylic acid chelating agents Download PDF

Info

Publication number
WO1991015466A3
WO1991015466A3 PCT/EP1991/000674 EP9100674W WO9115466A3 WO 1991015466 A3 WO1991015466 A3 WO 1991015466A3 EP 9100674 W EP9100674 W EP 9100674W WO 9115466 A3 WO9115466 A3 WO 9115466A3
Authority
WO
WIPO (PCT)
Prior art keywords
chelating agents
acid chelating
aminopolycarboxylic acid
chelants
aminopolycarboxylic
Prior art date
Application number
PCT/EP1991/000674
Other languages
French (fr)
Other versions
WO1991015466A2 (en
Inventor
Paal Rongved
Jo Klaveness
Harald Dugstad
Original Assignee
Cockbain Julian R M
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cockbain Julian R M, Nycomed As filed Critical Cockbain Julian R M
Publication of WO1991015466A2 publication Critical patent/WO1991015466A2/en
Publication of WO1991015466A3 publication Critical patent/WO1991015466A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Chelants of formula (I) (as given in claim 1) are disclosed. The chelants are of particular use in producing therapeutic, diagnostic and detoxification agents.
PCT/EP1991/000674 1990-04-09 1991-04-09 Aminopolycarboxylic acid chelating agents WO1991015466A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9007965.8 1990-04-09
GB909007965A GB9007965D0 (en) 1990-04-09 1990-04-09 Compounds

Publications (2)

Publication Number Publication Date
WO1991015466A2 WO1991015466A2 (en) 1991-10-17
WO1991015466A3 true WO1991015466A3 (en) 1991-11-28

Family

ID=10674118

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1991/000674 WO1991015466A2 (en) 1990-04-09 1991-04-09 Aminopolycarboxylic acid chelating agents

Country Status (3)

Country Link
AU (1) AU7661991A (en)
GB (1) GB9007965D0 (en)
WO (1) WO1991015466A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19507820A1 (en) * 1995-02-21 1996-08-22 Schering Ag Novel substituted DTPA derivatives, their metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics, and methods for producing the complexes and compositions
US6107090A (en) 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
IL158969A0 (en) 2001-06-01 2004-05-12 Cornell Res Foundation Inc Modified antibodies to prostate-specific membrane antigen and uses thereof
US7514078B2 (en) 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
CA2452288A1 (en) 2001-09-20 2003-03-27 Cornell Research Foundation, Inc. Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
ES2314272T3 (en) 2003-01-10 2009-03-16 Millennium Pharmaceuticals, Inc. METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER.
FI20065030L (en) * 2006-01-17 2007-07-18 Wallac Oy Neutral labeling reagents and conjugates derived from them

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324236A1 (en) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Novel complexing agents
EP0130934B1 (en) * 1983-07-01 1987-08-05 Schering Aktiengesellschaft Complexing agents, complexes and complex salts
EP0263059A2 (en) * 1986-09-26 1988-04-06 Schering Aktiengesellschaft Complexes amides
EP0299795A2 (en) * 1987-07-16 1989-01-18 Nycomed As Aminopolycarboxylic acids and derivatives thereof
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
WO1990001024A1 (en) * 1988-07-19 1990-02-08 Mallinckrodt, Inc. Novel magnetic resonance imaging agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324236A1 (en) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Novel complexing agents
EP0130934B1 (en) * 1983-07-01 1987-08-05 Schering Aktiengesellschaft Complexing agents, complexes and complex salts
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
EP0263059A2 (en) * 1986-09-26 1988-04-06 Schering Aktiengesellschaft Complexes amides
EP0299795A2 (en) * 1987-07-16 1989-01-18 Nycomed As Aminopolycarboxylic acids and derivatives thereof
WO1990001024A1 (en) * 1988-07-19 1990-02-08 Mallinckrodt, Inc. Novel magnetic resonance imaging agents

Also Published As

Publication number Publication date
AU7661991A (en) 1991-10-30
GB9007965D0 (en) 1990-06-06
WO1991015466A2 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
CA2140106A1 (en) Method of treating hyperproliferative vascular disease
DK0490823T3 (en)
MX9700538A (en) Use of droloxifene for the treatment of cardiovascular diseases.
CA2263561A1 (en) Thienopyrimidines
WO1991010645A3 (en) Chelants
AU7122291A (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
GR3023235T3 (en) Hydrogele prepared by using Alkenyl-phosphonic and phosphinic acid esters as cross-linking agents.
GR3019179T3 (en) Flupirtine in combination with antiparkinsonica against muscle bracing
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
WO1999049883A3 (en) Oxidized thymosin beta 4
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
IE791235L (en) Acyl-derivatives of carnitine.
EP0542914A4 (en) Improved diagnostic and therapeutic compositions
IL97426A0 (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
WO1991015466A3 (en) Aminopolycarboxylic acid chelating agents
GR3006349T3 (en)
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
CA2241825A1 (en) New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
CA2078700A1 (en) Imidazolylmethyl-pyridines
AU7664291A (en) Aminopolycarboxylic acid chelating agents
GR3017967T3 (en) Substituted pyrido-oxazines.
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
AU590952B2 (en) Photosensitizers and polymerizable compositions
ZA913920B (en) Therapeutic compound

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI JP NO US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI JP NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

CFP Corrected version of a pamphlet front page

Free format text: REVISED TITLE RECEIVED BY THE INTERNATIONAL BUREAU AFTER THE COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION

NENP Non-entry into the national phase

Ref country code: CA